FSH-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic

BACA JUGA:Inilah 5 Kutukan Allah SWT Terhadap Kaum Yahudi Diabadikan Dalam Al-Qur'an

CAPA-IVM is a novel approach to in-vitro maturation of oocytes recovered after no or minimal ovarian stimulation, that incorporates a capacitation step in the maturation of oocytes in vitro which enhances oocyte developmental competence. CAPA-IVM is a patient-friendly assisted reproductive technology method that may become an alternative option to conventional ovarian stimulation and IVF, with reduced treatment burden in some selected groups of patients. The worldwide rights to the CAPA-IVM technology are owned by Lavima Fertility, Inc. Lavima Fertility is developing a medical device for future application of this technology.